Pharmacy Times®
Specialty Pharmacy Times
  • Keeping an Eye on Hepatitis C Virus Drug Approvals
  • Community Specialty Pharmacy: The Time Is Now!
  • Specialty Pipeline Highlights
  • Evaluating and Elevating Specialty Pharmacists Through Certification
  • How Will Specialty Pharmacy Be Affected By Cost Containment?
  • Psoriatric Arthritis: An Overview
Breast Cancer Therapy Shows Long-Term Benefits
Eileen Oldfield, Associate Editor
Researchers found significant improvements in overall survival and in disease-free survival in patients who received trastuzumab in addition to chemotherapy.
The Ebola Epidemic: What You Need to Know
Michael R. Page, PharmD, RPh
Learn about the strains involved in the current and past epidemics, the features of the Ebola virus, information about aerosolized spread, and treatments in development.
Enterovirus Infection Increases Type 1 Diabetes Risk
Davy James, Associate Editor
Children infected with enterovirus have a 48% increased risk of developing type 1 diabetes.
Zontivity by Merck and Co, Inc
Michael R. Page, PharmD, RPh
The FDA has approved Zontivity (voraxapar) for prevention of thrombotic cardiovascular events in patients with peripheral artery disease or a history of myocardial infarction.
Opsumit by Actelion Pharmaceuticals US, Inc
Michael R. Page, PharmD, RPh
Opsumit (macitentan) was approved to reduce the risk of hospitalization and delay disease progression in patients with WHO group I pulmonary arterial hypertension.
Featured Video
Challenges Ahead for Specialty Pharmacy
Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Volume: 5
Number: 4
Conference Calendar
â—„        October 2014        â–º
Featured Company Profile
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2013
Intellisphere, LLC. All Rights Reserved.